Genomic Health Inc. (GHDX) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Join SI Premium – FREE
Genomic Health Inc. (NASDAQ: GHDX) reported Q1 EPS of ($0.01), $0.03 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $48.69 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Transact Technologies (TACT) Tops Q2 EPS by 1c
- Adecoagro S.A. (AGRO) Misses Q2 EPS by 63c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
